Effect of Reproducibility of Baseline Arrhythmia Induction on Drug Efficacy Predictions and Outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial fn1 fn1 This study was supported in part by Grant RO-1-HL34071 from the National Heart, Lung, and Blood Institute, and Grant M01-RR00064 from the National Center for Research Resources, Bethesda, Maryland; and by Bristol-Myers Squibb Company, Princeton, New Jersey; Knoll Pharmaceutical Company, Whippany, New Jersey; Boehringer-Ingelheim, Ridgefield, Connecticut; Parke-Davis, Morris Plains, New Jersey; and Ciba-Geigy, Summit, New Jersey.
Titel:
Effect of Reproducibility of Baseline Arrhythmia Induction on Drug Efficacy Predictions and Outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Trial fn1 fn1 This study was supported in part by Grant RO-1-HL34071 from the National Heart, Lung, and Blood Institute, and Grant M01-RR00064 from the National Center for Research Resources, Bethesda, Maryland; and by Bristol-Myers Squibb Company, Princeton, New Jersey; Knoll Pharmaceutical Company, Whippany, New Jersey; Boehringer-Ingelheim, Ridgefield, Connecticut; Parke-Davis, Morris Plains, New Jersey; and Ciba-Geigy, Summit, New Jersey.
Auteur:
Mann MD, David E. Hartz MS, Vernon Hahn MA, Elizabeth A. Reiter MD, PhD, Michael J.